BOL 303242-X,
BOL-303242-X,
BOL303242-X,
mapracorat,
R-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methyl-5-quinolyl)amino)methyl)pentan-2-ol,
ZK 245186,
Mapracorat,
887375-26-0,
UNII-145V79YBVP,
ZK-245186,
145V79YBVP,
BOL-303242-X,
ZK245186,
Mapracorat [USAN:INN],
Mapracorat (USAN),
ZK 245186,
GTPL9654,
SCHEMBL1877067,
CHEMBL2103876,
EX-A1913,
DB12041,
SB17318,
HY-14864,
CS-0003603,
D10136,
(2R)-1,1,1-Trifluoro-4-(5-fluoro-2,3-dihydro-1-benzofuran-7-yl)-4-methyl-2-(((2- methylquinolin-5-yl)amino)methyl)pentan-2-ol,
(R)-1,1,1-trifluoro-4-(5-fluoro-2,3-dihydrobenzofuran-7-yl)-4-methyl-2-(((2-methylquinolin-5-yl)amino)methyl)pentan-2-ol,
7-Benzofuranpropanol, 5-fluoro-2,3-dihydro-gamma,gamma-dimethyl-alpha-(((2-methyl-5-quinolinyl)amino)methyl)-alpha-(trifluoromethyl)-, (alphaR)-,
SEGRA, Intendis,
Mapracorat [USAN],
SEGRA, Schering AG,
D01IUS,
SEGRA (atopic dermatitis), Bayer,
BOL-303242X,
SEGRA (ophthalmic disease), Bausch & Lomb,
ZK-216348,
ZK-238587,
ZK-245186 (ophthalmic), Bausch & Lomb,
Mapracorat (ophthalmic, ocular inflammation),
Mapracorat Ophthalmic Suspension, Bausch & Lomb,
BOL-303242-X Ophthalmic Suspension, Bausch & Lomb,
Mapracorat (dermatological, atopic dermatitis), Intendis,
Mapracorat (ophthalmic, ocular inflammation), Bausch & Lomb,
Suppressor of pro-inflammatory mediators (eczema), Intendis,
Selective glucocorticoid receptor agonists (SEGRA), Schering AG,
Selective glucocorticoid receptor agonists (dermatology), Schering AG,
Selective glucocorticoid receptor agonists (SEGRA) Schering AG/AstraZeneca,
Selective glucocorticoid receptor agonist (ophthalmic disease), Bausch & Lomb,
Selective glucocorticoid receptor agonists (dermatological, eczema), Intendis,
Selective glucocorticoid receptor agonists (SEGRA) Bayer Schering/AstraZeneca,